Skip to content
The GLP-1 Verdict
Menu
Ranked #99 · Grade C

Ivy Rx review

Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

Visit Ivy Rx Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $175/mo (starting dose, compounded)
Tirzepatide
From $275/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Compounded only

The scorecard

Ivy Rx scored on our six published factors. See the methodology.

Real-world results75/100
Price honesty64/100
Prescriber access86/100
Formulary choice82/100
Cancellation fairness56/100
Member support74/100

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The verdict

Best for: Shoppers who want mainstream telehealth GLP-1 access. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

Ranked #99 of 499 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. On the board it sits between Harper Meds, 73/100 above and Kina at 73/100 below, with the Layla ruling the next one down.

A grade C is a ranking, not an instruction to stop looking: the closest rivals to Ivy Rx are ruled on the identical rubric, so the comparison is like for like. We have also ruled on it directly: CoreAge Rx vs Ivy Rx goes to CoreAge Rx, 94/100 to 73/100.

Visit Ivy Rx

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect Ivy Rx's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Ivy Rx's site. Not medical advice; see our disclosure.

← Back to all rankings